These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial. White NH, Sun W, Cleary PA, Danis RP, Davis MD, Hainsworth DP, Hubbard LD, Lachin JM, Nathan DM. Arch Ophthalmol; 2008 Dec; 126(12):1707-15. PubMed ID: 19064853 [Abstract] [Full Text] [Related]
4. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group. Diabetes Care; 1999 Jan; 22(1):99-111. PubMed ID: 10333910 [Abstract] [Full Text] [Related]
11. The effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) study. Purnell JQ, Zinman B, Brunzell JD, DCCT/EDIC Research Group. Circulation; 2013 Jan 15; 127(2):180-7. PubMed ID: 23212717 [Abstract] [Full Text] [Related]
14. Refractive Error and Retinopathy Outcomes in Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study. Hainsworth DP, Gao X, Bebu I, Das A, Olmos de Koo L, Barkmeier AJ, Tamborlane W, Lachin JM, Aiello LP, Diabetes Control and Complications Trial and Follow-up Epidemiology of Diabetes Interventions and Complications Research Group. Ophthalmology; 2021 Apr 15; 128(4):554-560. PubMed ID: 32941962 [Abstract] [Full Text] [Related]
15. Neuropathy and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Martin CL, Albers JW, Pop-Busui R, DCCT/EDIC Research Group. Diabetes Care; 2014 Apr 15; 37(1):31-8. PubMed ID: 24356595 [Abstract] [Full Text] [Related]
16. Diabetic retinopathy and other ocular findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Aiello LP, DCCT/EDIC Research Group. Diabetes Care; 2014 Apr 15; 37(1):17-23. PubMed ID: 24356593 [Abstract] [Full Text] [Related]
18. Patient-reported visual function outcomes improve after ranibizumab treatment in patients with vision impairment due to diabetic macular edema: randomized clinical trial. Mitchell P, Bressler N, Tolley K, Gallagher M, Petrillo J, Ferreira A, Wood R, Bandello F, RESTORE Study Group. JAMA Ophthalmol; 2013 Oct 15; 131(10):1339-47. PubMed ID: 23974915 [Abstract] [Full Text] [Related]
19. Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality. Writing Group for the DCCT/EDIC Research Group, Orchard TJ, Nathan DM, Zinman B, Cleary P, Brillon D, Backlund JY, Lachin JM. JAMA; 2015 Jan 06; 313(1):45-53. PubMed ID: 25562265 [Abstract] [Full Text] [Related]
20. Central visual function and the NEI-VFQ-25 near and distance activities subscale scores in people with type 1 and 2 diabetes. Cusick M, SanGiovanni JP, Chew EY, Csaky KG, Hall-Shimel K, Reed GF, Caruso RC, Ferris FL. Am J Ophthalmol; 2005 Jun 06; 139(6):1042-50. PubMed ID: 15953434 [Abstract] [Full Text] [Related] Page: [Next] [New Search]